Structure, function and dynamics in adenovirus maturation

Viruses

Volumn 6, Issue 11, 2014, Pages 4536-4570

  Mangel, Walter F ^a   Martín, Carmen San ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Adenovirus; DNA sliding; Infectivity; Protease; Uncoating; Virus stability

Indexed keywords

ACTIN; CORE PROTEIN; CYTOKERATIN 18; DOUBLE STRANDED DNA; PROTEINASE; RHODAMINE 110; SCAFFOLD PROTEIN; TUBULIN; VIMENTIN; VIRUS DNA; VIRAL PROTEIN;

ADENOVIRUS; CELL MATURATION; DIFFUSION; DNA PACKAGING; ELECTRON TOMOGRAPHY; ENZYME ACTIVITY; ENZYME INACTIVATION; FLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE; MASS SPECTROMETRY; MECHANICAL STRESS; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; REVIEW; VIRUS CAPSID; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS UNCOATING; ADENOVIRIDAE; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; VIRUS ASSEMBLY; VIRUS REPLICATION;

ADENOVIRIDAE;

ADENOVIRIDAE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84912544572     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6114536     Document Type: Review

References (145)

1. Berk, A.J. Adenoviridae: The viruses and their replication. In Fields Virology, 5th ed.; Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 2355-2394.
2. Harrach, B.; Benkő, M.; Both, G.; Brown, M.; Davison, A.; Echavarría, M.; Hess, M.; Jones, M.; Kajon, A.; Lehmkuhl, H.; et al. Family Adenoviridae. In Virus Taxonomy: Classification and Nomenclature of Viruses. Ninth Report of the International Committee on Taxonomy of Viruses; King, A., Adams, M., Carstens, E., Lefkowitz, E., Eds.; Elsevier: San Diego, CA, USA, 2011; pp. 95-111.
3. Lasaro, M.O.; Ertl, H.C. New insights on adenovirus as vaccine vectors. Mol. Ther. 2009, 17, 1333-1339.
4. Gonçalves, M.A.F.V.; de Vries, A.A.F. Adenovirus: From foe to friend. Rev. Med. Virol. 2006, 16, 167-186.
5. Yamamoto, M.; Curiel, D.T. Current issues and future directions of oncolytic adenoviruses. Mol. Ther. 2010, 18, 243-250.
6. Castón, J.R.; Carrascosa, J.L. The basic architecture of viruses. Sub-Cell. Biochem. 2013, 68, 53-75.
7. San Martín, C. Latest Insights on Adenovirus Structure and Assembly. Viruses 2012, 4, 847-877.
8. Liu, H.; Jin, L.; Koh, S.B.; Atanasov, I.; Schein, S.; Wu, L.; Zhou, Z.H. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 2010, 329, 1038-1043.
9. Reddy, V.S.; Natchiar, S.K.; Stewart, P.L.; Nemerow, G.R. Crystal structure of human adenovirus at 3.5 A resolution. Science 2010, 329, 1071-1075.
10. Reddy, V.S.; Nemerow, G.R. Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection. Proc. Natl. Acad. Sci. USA 2014, 111, 11715-11720.
11. Campos, S.K. New structural model of adenoviral cement proteins is not yet concrete. Proc. Natl. Acad. Sci. USA 2014, 111, E4542-E4543.
12. Saban, S.D.; Silvestry, M.; Nemerow, G.R.; Stewart, P.L. Visualization of α-helices in a 6 Å resolution cryoEM structure of adenovirus allows refinement of capsid protein assignments. J. Virol. 2006, 80, 12049-12059.
13. San Martín, C.; Glasgow, J.N.; Borovjagin, A.; Beatty, M.S.; Kashentseva, E.A.; Curiel, D.T.; Marabini, R.; Dmitriev, I.P. Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid. J. Mol. Biol. 2008, 383, 923-934.
14. Scheres, S.H.W.; Marabini, R.; Lanzavecchia, S.; Cantele, F.; Rutten, T.; Fuller, S.D.; Carazo, J.M.; Burnett, R.M.; San Martín, C. Classification of single-projection reconstructions for cryo-electron microscopy data of icosahedral viruses. J. Struct. Biol. 2005, 151, 79-91.
15. Ma, H.C.; Hearing, P. Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging. J. Virol. 2011, 85, 7849-7855.
16. Blainey, P.C.; Graziano, V.; Pérez-Berná, A.J.; McGrath, W.J.; Flint, S.J.; San Martín, C.; Xie, X.S.; Mangel, W.F. Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space: IV. Viral proteinase slides along DNA to locate and process its substrates. J. Biol. Chem. 2013, 288, 2092-2102.
17. Greber, U.F.; Willetts, M.; Webster, P.; Helenius, A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993, 75, 477-486.
18. Van Oostrum, J.; Burnett, R.M. Molecular composition of the adenovirus type 2 virion. J. Virol. 1985, 56, 439-448.
19. Benevento, M.; di Palma, S.; Snijder, J.; Moyer, C.L.; Reddy, V.S.; Nemerow, G.R.; Heck, A.J. Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics. J. Biol. Chem. 2014, 289, 11421-11430.
20. Vayda, M.E.; Rogers, A.E.; Flint, S.J. The structure of nucleoprotein cores released from adenovirions. Nucleic Acids Res. 1983, 11, 441-460.
21. Mirza, M.A.; Weber, J. Structure of adenovirus chromatin. Biochim. Biophys. Acta 1982, 696, 76-86.
22. Arnberg, N. Adenovirus receptors: Implications for targeting of viral vectors. Trends Pharmacol. Sci. 2012, 33, 442-448.
23. Wickham, T.J.; Mathias, P.; Cheresh, D.A.; Nemerow, G.R. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 1993, 73, 309-319.
24. Nakano, M.Y.; Boucke, K.; Suomalainen, M.; Stidwill, R.P.; Greber, U.F. The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 2000, 74, 7085-7095.
25. Lindert, S.; Silvestry, M.; Mullen, T.M.; Nemerow, G.R.; Stewart, P.L. Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J. Virol. 2009, 83, 11491-11501.
26. Puntener, D.; Engelke, M.F.; Ruzsics, Z.; Strunze, S.; Wilhelm, C.; Greber, U.F. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J. Virol. 2011, 85, 481-496.
27. Wiethoff, C.M.; Wodrich, H.; Gerace, L.; Nemerow, G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 2005, 79, 1992-2000.
28. Wodrich, H.; Henaff, D.; Jammart, B.; Segura-Morales, C.; Seelmeir, S.; Coux, O.; Ruzsics, Z.; Wiethoff, C.M.; Kremer, E.J. A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog. 2010, 6, e1000808.
29. Burckhardt, C.J.; Suomalainen, M.; Schoenenberger, P.; Boucke, K.; Hemmi, S.; Greber, U.F. Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 2011, 10, 105-117.
30. Maier, O.; Galan, D.L.; Wodrich, H.; Wiethoff, C.M. An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 2010, 402, 11-19.
31. Suomalainen, M.; Luisoni, S.; Boucke, K.; Bianchi, S.; Engel, D.A.; Greber, U.F. A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J. Virol. 2013, 87, 12367-12379.
32. Bremner, K.H.; Scherer, J.; Yi, J.; Vershinin, M.; Gross, S.P.; Vallee, R.B. Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 2009, 6, 523-535.
33. Greber, U.F.; Suomalainen, M.; Stidwill, R.P.; Boucke, K.; Ebersold, M.W.; Helenius, A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 1997, 16, 5998-6007.
34. Trotman, L.C.; Mosberger, N.; Fornerod, M.; Stidwill, R.P.; Greber, U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 2001, 3, 1092-1100.
35. Suomalainen, M.; Nakano, M.Y.; Keller, S.; Boucke, K.; Stidwill, R.P.; Greber, U.F. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 1999, 144, 657-672.
36. Wang, I.H.; Suomalainen, M.; Andriasyan, V.; Kilcher, S.; Mercer, J.; Neef, A.; Luedtke, N.W.; Greber, U.F. Tracking viral genomes in host cells at single-molecule resolution. Cell Host Microbe 2013, 14, 468-480.
37. Walkiewicz, M.P.; Morral, N.; Engel, D.A. Accurate single-day titration of adenovirus vectors based on equivalence of protein VII nuclear dots and infectious particles. J. Virol. Methods 2009, 159, 251-258.
38. Gustin, K.E.; Imperiale, M.J. Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J. Virol. 1998, 72, 7860-7870.
39. Guimet, D.; Hearing, P. The Adenovirus L4-22K Protein Has Distinct Functions in the Posttranscriptional Regulation of Gene Expression and Encapsidation of the Viral Genome. J. Virol. 2013, 87, 7688-7699.
40. Wu, K.; Guimet, D.; Hearing, P. The Adenovirus L4-33K Protein Regulates both Late Gene Expression Patterns and Viral DNA Packaging. J. Virol. 2013, 87, 6739-6747.
41. Ostapchuk, P.; Almond, M.; Hearing, P. Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein. J. Virol. 2011, 85, 5524-5531.
42. Zhang, W.; Imperiale, M.J. Interaction of the adenovirus IVa2 protein with viral packaging sequences. J. Virol. 2000, 74, 2687-2693.
43. Ostapchuk, P.; Yang, J.; Auffarth, E.; Hearing, P. Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J. Virol. 2005, 79, 2831-2838.
44. Perez-Romero, P.; Tyler, R.E.; Abend, J.R.; Dus, M.; Imperiale, M.J. Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro. J. Virol. 2005, 79, 2366-2374.
45. Ostapchuk, P.; Anderson, M.E.; Chandrasekhar, S.; Hearing, P. The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. J. Virol. 2006, 80, 6973-6981.
46. Hasson, T.B.; Ornelles, D.A.; Shenk, T. Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers. J. Virol. 1992, 66, 6133-6142.
47. Ishibashi, M.; Maizel, J.V., Jr. The polypeptides of adenovirus. V. Young virions, structural intermediate between top components and aged virions. Virology 1974, 57, 409-424.
48. Weber, J.M. Role of endoprotease in adenovirus infection. In Adenoviruses: Basic Biology to Gene Therapy; Seth, P., Ed.; R.G. Landes: Austin, TX, USA, 1999; pp. 79-83.
49. Cotten, M.; Weber, J.M. The adenovirus protease is required for virus entry into host cells. Virology 1995, 213, 494-502.
50. Gastaldelli, M.; Imelli, N.; Boucke, K.; Amstutz, B.; Meier, O.; Greber, U.F. Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 2008, 9, 2265-2278.
51. Weber, J. Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J. Virol. 1976, 17, 462-471.
52. Mangel, W.F.; Toledo, D.L.; Brown, M.T.; Martin, J.H.; McGrath, W.J. Characterization of three components of human adenovirus proteinase activity in vitro. J. Biol. Chem. 1996, 271, 536-543.
53. Blanche, F.; Monegier, B.; Faucher, D.; Duchesne, M.; Audhuy, F.; Barbot, A.; Bouvier, S.; Daude, G.; Dubois, H.; Guillemin, T.; et al. Polypeptide composition of an adenovirus type 5 used in cancer gene therapy. J. Chromatogr. A 2001, 921, 39-48.
54. Challberg, M.D.; Kelly, T.J., Jr. Processing of the adenovirus terminal protein. J. Virol. 1981, 38, 272-277.
55. Davison, A.J.; Benkő, M.; Harrach, B. Genetic content and evolution of adenoviruses. J. Gen. Virol. 2003, 84, 2895-2908.
56. Webster, A.; Kemp, G. The active adenovirus protease is the intact L3 23K protein. J. Gen. Virol. 1993, 74, 1415-1420.
57. Anderson, C.W. The proteinase polypeptide of adenovirus serotype 2 virions. Virology 1990, 177, 259-272.
58. Brown, M.T.; McGrath, W.J.; Toledo, D.L.; Mangel, W.F. Different modes of inhibition of human adenovirus proteinase, probably a cysteine proteinase, by bovine pancreatic trypsin inhibitor. FEBS Lett. 1996, 388, 233-237.
59. Zhang, W.; Arcos, R. Interaction of the adenovirus major core protein precursor, pVII, with the viral DNA packaging machinery. Virology 2005, 334, 194-202.
60. Pérez-Berná, A.J.; Mangel, W.F.; McGrath, W.J.; Graziano, V.; Flint, J.; San Martín, C. Processing of the L1 52/55k protein by the adenovirus protease: A new substrate and new insights into virion maturation. J. Virol. 2014, 88, 1513-1524.
61. Yeh-Kai, L.; Akusjarvi, G.; Alestrom, P.; Pettersson, U.; Tremblay, M.; Weber, J. Genetic identification of an endopeptidase encoded by the adenovirus genome. J. Mol. Biol. 1983, 167, 217-222.
62. Anderson, C.W. Expression and purification of the adenovirus proteinase polypeptide and of a synthetic proteinase substrate. Protein Express. Purif. 1993, 4, 8-15.
63. Tihanyi, K.; Bourbonniere, M.; Houde, A.; Rancourt, C.; Weber, J.M. Isolation and properties of adenovirus type 2 proteinase. J. Biol. Chem. 1993, 268, 1780-1785.
64. Webster, A.; Hay, R.T.; Kemp, G. The adenovirus protease is activated by a virus-coded disulphide-linked peptide. Cell 1993, 72, 97-104.
65. Rancourt, C.; Keyvani-Amineh, H.; Sircar, S.; Labrecque, P.; Weber, J.M. Proline 137 is critical for adenovirus protease encapsidation and activation but not enzyme activity. Virology 1995, 209, 167-173.
66. Imelli, N.; Ruzsics, Z.; Puntener, D.; Gastaldelli, M.; Greber, U.F. Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol. J. 2009, 6, 174.
67. Diouri, M.; Keyvani-Amineh, H.; Geoghegan, K.F.; Weber, J.M. Cleavage efficiency by adenovirus protease is site-dependent. J. Biol. Chem. 1996, 271, 32511-32514.
68. Webster, A.; Russell, S.; Talbot, P.; Russell, W.C.; Kemp, G.D. Characterization of the adenovirus proteinase: Substrate specificity. J. Gen. Virol. 1989, 70, 3225-3234.
69. Webster, A.; Leith, I.R.; Nicholson, J.; Hounsell, J.; Hay, R.T. Role of preterminal protein processing in adenovirus replication. J. Virol. 1997, 71, 6381-6389.
70. Notredame, C.; Higgins, D.G.; Heringa, J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 2000, 302, 205-217.
71. Waterhouse, A.M.; Procter, J.B.; Martin, D.M.; Clamp, M.; Barton, G.J. Jalview Version 2-A multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25, 1189-1191.
72. Leytus, S.P.; Melhado, L.L.; Mangel, W.F. Rhodamine-based compounds as fluorogenic substrates for serine proteases. Biochem. J. 1983, 209, 299-307.
73. Leytus, S.P.; Patterson, W.L.; Mangel, W.F. New class of sensitive, specific, and selective substrates for serine proteinases: Fluorogenic, amino acid peptide derivatives of Rhodamine. Biochem. J. 1983, 215, 253-260.
74. Webster, A.; Russell, W.C.; Kemp, G.D. Characterization of the adenovirus proteinase; development and use of a specific peptide assay. J. Gen. Virol. 1989, 70, 3215-3223.
75. Mangel, W.F.; McGrath, W.J.; Toledo, D.L.; Anderson, C.W. Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993, 361, 274-275.
76. McGrath, W.J.; Abola, A.P.; Toledo, D.L.; Brown, M.T.; Mangel, W.F. Characterization of human adenovirus proteinase activity in disrupted virus particles. Virology 1996, 217, 131-138.
77. Bajpayee, N.S.; McGrath, W.J.; Mangel, W.F. Interaction of the adenovirus proteinase with protein cofactors with high negative charge densities. Biochemistry 2005, 44, 8721-8729.
78. McGrath, W.J.; Baniecki, M.L.; Li, C.; McWhirter, S.M.; Brown, M.T.; Toledo, D.L.; Mangel, W.F. Human adenovirus proteinase: DNA binding and stimulation of proteinase activity by DNA. Biochemistry 2001, 40, 13237-13245.
79. Joshua-Tor, L.; Xu, H.E.; Johnston, S.A.; Rees, D.C. Crystal structure of a conserved protease that binds DNA: The bleomycin hydrolase, Gal6. Science 1995, 269, 945-950.
80. Staufenbiel, M.; Epple, P.; Deppert, W. Progressive reorganization of the host cell cytoskeleton during adenovirus infection. J. Virol. 1986, 60, 1186-1191.
81. Chen, P.H.; Ornelles, D.A.; Shenk, T. The adenovirus L3 23-Kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 1993, 67, 3507-3514.
82. Brown, M.T.; McBride, K.M.; Baniecki, M.L.; Reich, N.C.; Marriott, G.; Mangel, W.F. Actin can act as a cofactor for a viral proteinase, in the cleavage of the cytoskeleton. J. Biol. Chem. 2002, 277, 46298-46303.
83. Schutt, C.E.; Myslik, J.C.; Rozycki, M.D.; Goonesekere, N.C.; Lindberg, U. The structure of crystalline profilin-beta-actin. Nature 1993, 365, 810-816.
84. Akusjarvi, G.; Persson, H.J. Gene and mRNA for precursor polypeptide VI from adenovirus type 2. J. Virol. 1981, 38, 469-482.
85. Cai, F.; Weber, J.M. Organization of the avian adenovirus genome and the structure of its endopeptidase. Virology 1993, 196, 358-362.
86. McGrath, W.J.; Ding, J.; Sweet, R.M.; Mangel, W.F. Preparation and crystallization of a complex between human adenovirus serotype 2 proteinase and its 11-amino-acid cofactor pVIc. J. Struct. Biol. 1996, 117, 77-79.
87. Ding, J.; McGrath, W.J.; Sweet, R.M.; Mangel, W.F. Crystal structure of the human adenovirus proteinase with its 11 amino acid cofactor. EMBO J. 1996, 15, 1778-1783.
88. McGrath, W.J.; Ding, J.; Sweet, R.M.; Mangel, W.F. Crystallographic structure at 1.6-Å resolution of the human adenovirus proteinase in a covalent complex with its 11-amino-acid peptide cofactor: Insights on a new fold. Biochem. Biophys. Acta 2003, 1648, 1-11.
89. Mangel, W.F.; Toledo, D.L.; Ding, J.; Sweet, R.M.; McGrath, W.J. Temporal and spatial control of the adenovirus proteinase by both a peptide and the viral DNA. Trends Biochem. Sci. 1997, 22, 393-398.
90. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25, 1605-1612.
91. Storer, A.C.; Menard, R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 1994, 244, 486-500.
92. Robertus, J.D.; Kraut, J.; Alden, R.A.; Birktoft, J.J. Subtilisin; a stereochemical mechanism involving transition-state stabilization. Biochemistry 1972, 11, 4293-4303.
93. Drenth, J.; Kalk, K.H.; Swen, H.M. Binding of chloromethyl ketone substrate analogues to crystalline papain. Biochemistry 1976, 15, 3731-3738.
94. Baniecki, M.L.; McGrath, W.J.; Mangel, W.F. Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: III. Atomic resolution structure of the nascent form of the adenovirus proteinase. J. Biol. Chem. 2013, 288, 2081-2091.
95. Gupta, S.; Mangel, W.F.; McGrath, W.J.; Perek, J.L.; Lee, D.W.; Takamoto, K.; Chance, M.R. DNA binding provides a molecular strap activating the adenovirus proteinase. Mol. Cell. Proteomics 2004, 3, 950-959.
96. Gupta, S.; Mangel, W.F.; Sullivan, M.; Takamoto, K.G.; Chance, M.R. Mapping a functional viral protein in solution using synchrotron X-ray footprinting technology. Synchrotron Radiat. News 2005, 18, 25-34.
97. Baniecki, M.L.; McGrath, W.J.; McWhirter, S.M.; Li, C.; Toledo, D.L.; Pellicena, P.; Barnard, D.L.; Thorn, K.S.; Mangel, W.F. Interaction of the human adenovirus proteinase with its 11-amino acid cofactor pVIc. Biochemistry 2001, 40, 12349-12356.
98. Baniecki, M.L.; McGrath, W.J.; McWhirter, S.M.; Li, C.; Toledo, D.L.; Pellicena, P.; Barnard, D.L.; Thorn, K.S.; Mangel, W.F. Interaction of the human adenovirus proteinase with its 11-amino acid cofactor pVIc. Biochemistry 2001, 41, 430.
99. McGrath, W.J.; Baniecki, M.L.; Peters, E.; Green, D.T.; Mangel, W.F. Roles of two conserved cysteine residues in the activation of human adenovirus proteinase. Biochemistry 2001, 40, 14468-14474.
100. McGrath, W.J.; Aherne, K.S.; Mangel, W.F. In the virion, the 11-amino-acid peptide cofactor pVIc is covalently linked to the adenovirus proteinase. Virology 2002, 296, 234-240.
101. Bogan, A.A.; Thorn, K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 1998, 280, 1-9.
102. Russell, W.C.; Precious, B. Nucleic acid-binding properties of adenovirus structural polypeptides. J. Gen. Virol. 1982, 63, 69-79.
103. Record, M.T., Jr.; Lohman, M.L.; de Haseth, P. Ion effects on ligand-nucleic acid interactions. J. Mol. Biol. 1976, 107, 145-158.
104. Graziano, V.; McGrath, W.J.; Suomalainen, M.; Greber, U.F.; Freimuth, P.; Blainey, P.C.; Luo, G.; Xie, X.S.; Mangel, W.F. Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: I. Binding to DNA and to hexon of the precursor to protein VI, pVI, of human adenovirus. J. Biol. Chem. 2013, 288, 2059-2067.
105. Casjens, S. Principles of virion structure, function and assembly. In Structural Biology of Viruses; Chiu, W., Burnett, R.M., Garcea, R.L., Eds.; Oxford University Press: Oxford, UK, 1997; pp. 3-37.
106. Mangenot, S.; Keller, S.; Radler, J. Transport of nucleosome core particles in semidilute DNA solutions. Biophys. J. 2003, 85, 1817-1825.
107. Russell, W.C. Adenoviruses: Update on structure and function. J. Gen. Virol. 2009, 90, 1-20.
108. Graziano, V.; Luo, G.; Blainey, P.C.; Pérez-Berná, A.J.; McGrath, W.J.; Flint, S.J.; San Martín, C.; Xie, X.S.; Mangel, W.F. Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: II. Adenovirus proteinase is activated in an unusual one-dimensional biochemical reaction. J. Biol. Chem. 2013, 288, 2068-2080.
109. Webster, A.; Leith, I.R.; Hay, R.T. Activation of adenovirus-coded protease and processing of preterminal protein. J. Virol. 1994, 68, 7292-7300.
110. Chatterjee, P.K.; Vayda, M.E.; Flint, S.J. Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J. Mol. Biol. 1986, 188, 23-37.
111. Greber, U.F. Virus assembly and disassembly: The adenovirus cysteine protease as a trigger factor. Rev. Med. Virol. 1998, 8, 213-222.
112. Blainey, P.C.; Luo, G.; Kou, S.C.; Mangel, W.F.; Verdine, G.L.; Bagchi, B.; Xie, X.S. Nonspecifically bound proteins spin while diffusing along DNA. Nat. Struct. Mol. Biol. 2009, 16, 1224-1229.
113. Brandt, C.D.; Kim, H.W.; Vargosdo, A.J.; Jefferies, B.C.; Arrobio, J.O.; Rindge, B.; Parrott, R.H.; Chanock, R.M. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am. J. Epidemiol. 1969, 90, 484-500.
114. Mallet, R.; Riberre, M.; Bonnenfant, F.; Labrune, B.; Reyrole, L. Les pneumopathies graves a adeno-virus. Arch. Fr. Pediatr. 1966, 23, 1057-1073.
115. Kohoo, S.H.; Bailey, A.S.; de Jong, J.C.; Mandal, B.K. Adenovirus infections in human immunodeficiency virus-positive patients: Clinical features and molecular epidemiology. J. Infect. Dis. 1995, 172, 629-637.
116. Mogabgab, W.J. Mycoplasma pneumonia and adenovirus respiratory illnesses in military and university personnel. Am. Rev. Respir. Dis. 1968, 97, 345-358.
117. Gray, C.G.; Callahan, J.D.; Hawksworth, A.W.; Fisher, C.A.; Gaydos, J.C. Respiratory diseases among U.S. military personnel: Countering emerging threats. Emerg. Infect. Dis. 1999, 5, 379-385.
118. Atkinson, R.L.; Dhurandhar, N.V.; Allison, D.B.; Bown, R.L.; Israel, B.A.; Albu, J.B.; Augustus, A.S. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. 2005, 29, 281-286.
119. Centers for Disease Control and Prevention (CDC). Acute respiratory disease associated with adenovirus serotype 14-Four states, 2006-2007. MMWR 2007, 56, 1181-1184.
120. Mangel, W.F.; Brown, M.T.; Baniecki, M.L.; Barnard, D.L.; McGrath, W.J. Prevention of viral drug resistance by novel combination therapy. Curr. Opin. Investig. Drugs 2001, 2, 613-616.
121. Mangel, W.F.; McGrath, W.J.; Brown, M.T.; Baniecki, M.L.; Barnard, D.L.; Pang, Y.P. A new form of antiviral combination therapy predicted to prevent resistance from arising, and a model system to test it. Curr. Med. Chem. 2001, 8, 933-939.
122. Mangel, W.F.; Toledo, D.L.; Brown, M.T.; Ding, J.; Sweet, R.M.; Barnard, D.L.; McGrath, W.J. Adenovirus proteinase-antiviral target for triple-combination therapy on a single enzyme: Potential inhibitor-binding sites. In Proteases as Targets for Therapy; von der Helm, K., Korant, B.D., Cheronis, J.C., Eds.; Springer: Berlin, Germany, 2000; Volume 140, pp. 145-158.
123. Pang, Y.-P.; Xu, K.; Kollmeyer, T.M.; Perola, E.; McGrath, W.J.; Green, D.T.; Mangel, W.F. Discovery of a new inhibitor lead of adenovirus proteinase: Steps toward selective, irreversible inhibitors of cysteine proteinases. FEBS Lett. 2001, 502, 93-97.
124. McGrath, W.J.; Graziano, V.; Mangel, W.F. First generation inhibitors of the adenovirus proteinase. FEBS Lett. 2013, 587, 2332-2339.
125. Veesler, D.; Johnson, J.E. Virus Maturation. Annu. Rev. Biophys. 2012, 41, 473-496.
126. Johnson, J.E. Virus particle maturation: Insights into elegantly programmed nanomachines. Curr. Opin. Struct. Biol. 2010, 20, 210-216.
127. Silvestry, M.; Lindert, S.; Smith, J.G.; Maier, O.; Wiethoff, C.M.; Nemerow, G.R.; Stewart, P.L. Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J. Virol. 2009, 83, 7375-7383.
128. Pérez-Berná, A.J.; Marabini, R.; Scheres, S.H.W.; Menéndez-Conejero, R.; Dmitriev, I.P.; Curiel, D.T.; Mangel, W.F.; Flint, S.J.; San Martín, C. Structure and uncoating of immature adenovirus. J. Mol. Biol. 2009, 392, 547-557.
129. Snijder, J.; Benevento, M.; Moyer, C.L.; Reddy, V.; Nemerow, G.R.; Heck, A.J. The cleaved N-terminus of pVI binds peripentonal hexons in mature adenovirus. J. Mol. Biol. 2014, 426, 1971-1979.
130. Hannan, C.; Raptis, L.H.; Dery, C.V.; Weber, J. Biological and structural studies with an adenovirus type 2 temperature-sensitive mutant defective for uncoating. Intervirology 1983, 19, 213-223.
131. Pérez-Berná, A.J.; Ortega-Esteban, A.; Menéndez-Conejero, R.; Winkler, D.C.; Menéndez, M.; Steven, A.C.; Flint, S.J.; de Pablo, P.J.; San Martín, C. The role of capsid maturation on adenovirus priming for sequential uncoating. J. Biol. Chem. 2012, 287, 31582-31595.
132. Johnson, J.E.; Chiu, W. DNA packaging and delivery machines in tailed bacteriophages. Curr. Opin. Struct. Biol. 2007, 17, 237-243.
133. Hogle, J.M. Poliovirus cell entry: Common structural themes in viral cell entry pathways. Annu. Rev. Microbiol. 2002, 56, 677-702.
134. Ortega-Esteban, A.; Pérez-Berná, A.J.; Menéndez-Conejero, R.; Flint, S.J.; San Martín, C.; de Pablo, P.J. Monitoring dynamics of human adenovirus disassembly induced by mechanical fatigue. Sci. Rep. 2013, 3, doi:10.1038/srep01434.
135. Nociari, M.; Ocheretina, O.; Schoggins, J.W.; Falck-Pedersen, E. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 2007, 81, 4145-4157.
136. Gustin, K.E.; Lutz, P.; Imperiale, M.J. Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection. J. Virol. 1996, 70, 6463-6467.
137. Rekosh, D.M.; Russell, W.C.; Bellet, A.J.; Robinson, A.J. Identification of a protein linked to the ends of adenovirus DNA. Cell 1977, 11, 283-295.
138. Stillman, B.W.; Lewis, J.B.; Chow, L.T.; Mathews, M.B.; Smart, J.E. Identification of the gene and mRNA for the adenovirus terminal protein precursor. Cell 1981, 23, 497-508.
139. Liu, H.; Naismith, J.H.; Hay, R.T. Adenovirus DNA replication. In Adenoviruses: Model and Vectors in Virus Host Interactions. Current Topics in Microbiology and Immunology; Doerfler, W., Böhm, P., Eds.; Springer-Verlag: Heidelberg, Germany, 2003; Volume 272, pp. 131-164.
140. Khittoo, G.; Delorme, L.; Dery, C.V.; Tremblay, M.L.; Weber, J.M.; Bibor-Hardy, V.; Simard, R. Role of the nuclear matrix in adenovirus maturation. Virus Res. 1986, 4, 391-403.
141. King, A.J.; van der Vliet, P.C. A precursor terminal protein-trinucleotide intermediate during initiation of adenovirus DNA replication: Regeneration of molecular ends in vitro by a jumping back mechanism. EMBO J. 1994, 13, 5786-5792.
142. Pronk, R.; Stuiver, M.H.; van der Vliet, P.C. Adenovirus DNA replication: The function of the covalently bound terminal protein. Chromosoma 1992, 102, S39-S45.
143. Kato, S.E.; Chahal, J.S.; Flint, S.J. Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein. J. Virol. 2012, 86, 13554-13565.
144. Kuhlbrandt, W. Cryo-EM enters a new era. eLife 2014, 3, e03678.
145. Uetrecht, C.; Heck, A.J. Modern biomolecular mass spectrometry and its role in studying virus structure, dynamics, and assembly. Angew. Chem. Int. Ed. Engl. 2011, 50, 8248-8262.